Shao Z - Search Results

1

Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis.

Guo L, Wang Y, Yang W, Wang C, Guo T, Yang J, Shao Z, Cai G, Cai S, Zhang L, Hu X, Xu Y. Guo L, et al. Among authors: shao z. Gastroenterology. 2023 Aug;165(2):414-428.e7. doi: 10.1053/j.gastro.2023.04.029. Epub 2023 May 3. Gastroenterology. 2023. PMID: 37146911 Free article.

2

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation.

Jin X, Xu XE, Jiang YZ, Liu YR, Sun W, Guo YJ, Ren YX, Zuo WJ, Hu X, Huang SL, Shen HJ, Lan F, He YF, Hu GH, Di GH, He XH, Li DQ, Liu S, Yu KD, Shao ZM. Jin X, et al. Sci Adv. 2019 Mar 6;5(3):eaat9820. doi: 10.1126/sciadv.aat9820. eCollection 2019 Mar. Sci Adv. 2019. PMID: 30854423 Free PMC article.

3

Identification of a novel signature with prognostic value in triple-negative breast cancer through clinico-transcriptomic analysis.

Chen C, Lin CJ, Li SY, Hu X, Shao ZM. Chen C, et al. Ann Transl Med. 2022 Oct;10(20):1095. doi: 10.21037/atm-22-1931. Ann Transl Med. 2022. PMID: 36388802 Free PMC article.

4

An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression.

Lu XX, Yang WX, Pei YC, Luo H, Li XG, Wang YJ, Zhang GL, Ling H, Shao ZM, Hu X. Lu XX, et al. Cancer Res. 2023 Jun 15;83(12):2000-2015. doi: 10.1158/0008-5472.CAN-22-0536. Cancer Res. 2023. PMID: 37057875

5

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities.

Chen C, Lin CJ, Pei YC, Ma D, Liao L, Li SY, Fan L, Di GH, Wu SY, Liu XY, Wang YJ, Hong Q, Zhang GL, Xu LL, Li BB, Huang W, Shi JX, Jiang YZ, Hu X, Shao ZM. Chen C, et al. Cell Discov. 2023 Dec 19;9(1):125. doi: 10.1038/s41421-023-00614-3. Cell Discov. 2023. PMID: 38114467 Free PMC article.

6

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.

Fan L, Wang ZH, Ma LX, Wu SY, Wu J, Yu KD, Sui XY, Xu Y, Liu XY, Chen L, Zhang WJ, Jin X, Xiao Q, Shui RH, Xiao Y, Wang H, Yang YS, Huang XY, Cao AY, Li JJ, Di GH, Liu GY, Yang WT, Hu X, Xia Y, Liang QN, Jiang YZ, Shao ZM. Fan L, et al. Lancet Oncol. 2024 Feb;25(2):184-197. doi: 10.1016/S1470-2045(23)00579-X. Epub 2024 Jan 8. Lancet Oncol. 2024. PMID: 38211606 Clinical Trial.

7

Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.

Jiang YZ, Ma D, Jin X, Xiao Y, Yu Y, Shi J, Zhou YF, Fu T, Lin CJ, Dai LJ, Liu CL, Zhao S, Su GH, Hou W, Liu Y, Chen Q, Yang J, Zhang N, Zhang WJ, Liu W, Ge W, Yang WT, You C, Gu Y, Kaklamani V, Bertucci F, Verschraegen C, Daemen A, Shah NM, Wang T, Guo T, Shi L, Perou CM, Zheng Y, Huang W, Shao ZM. Jiang YZ, et al. Nat Cancer. 2024 Apr;5(4):673-690. doi: 10.1038/s43018-024-00725-0. Epub 2024 Feb 12. Nat Cancer. 2024. PMID: 38347143

8

Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low Breast Cancer.

Han BY, Chen C, Luo H, Lin CJ, Han XC, Nasir J, Shi JX, Huang W, Shao ZM, Ling H, Hu X. Han BY, et al. Cancer Lett. 2024 Apr 28;588:216763. doi: 10.1016/j.canlet.2024.216763. Epub 2024 Feb 24. Cancer Lett. 2024. PMID: 38403109 Free article.

9

Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.

Lin CJ, Jin X, Ma D, Chen C, Ou-Yang Y, Pei YC, Zhou CZ, Qu FL, Wang YJ, Liu CL, Fan L, Hu X, Shao ZM, Jiang YZ. Lin CJ, et al. Cancer Cell. 2024 Apr 8;42(4):701-719.e12. doi: 10.1016/j.ccell.2024.03.006. Cancer Cell. 2024. PMID: 38593782

10

Somatic mutations in a multigene panel and impact on prognosis based on TP53 status in Chinese HER2-positive patients undergoing neoadjuvant therapy: A single-institution retrospective cohort.

Xiong M, Wang X, Liu D, Xiu B, Zhang Q, Chi W, Goh CW, Zhang L, Chen M, Ren H, Shao ZM, Yang B, Wu J. Xiong M, et al. Cancer Med. 2024 Jan;13(2):e6955. doi: 10.1002/cam4.6955. Cancer Med. 2024. PMID: 38379328 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,368 results

Search Page